Pacer Advisors, Inc. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
Pacer Advisors, Inc. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$75,000
-26.5%
4,604
-4.1%
0.00%
-50.0%
Q4 2020$102,000
+72.9%
4,800
+19.8%
0.00%
+100.0%
Q3 2020$59,000
-73.5%
4,006
-43.2%
0.00%
-87.5%
Q3 2018$223,000
+669.0%
7,053
+340.8%
0.01%
+300.0%
Q4 2017$29,0001,6000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders